Contract Service Directory

Bellwyck Pharma Services





Company Headquarters

1 Rimini Mews
Mississauga, ON L5N 4K1
Canada

Company Description

At Bellwyck Pharma Services, we are pleased to be a one-stop solution provider, offering a comprehensive suite of services for both commercial and clinical supply chain solutions. We are uniquely positioned to provide full service commercial packaging, including pouching, blistering, and bottling along with a wide range of secondary packaging offerings. Our clinical services group provides extensive clinical trial packaging, labeling, and logistics through our US, Canadian and European facilities. At Bellwyck, we have the flexibility to handle orders of any size, from low volume custom packaging to high volume requirements. Our first-class project management and consulting support will ensure the utilization of cost-efficient packaging strategies while launching your projects on schedule. All of our facilities are cGMP-compliant and are strategically located to meet our customers’ supply chain needs.

Contract Service Directory

    Related Content

    • Bio News | Biosimilars
      Know the Challenges of Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best Practices for a Competitive Market
      Jerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18

    • Clinical Trials | Collaborations & Alliances | Drug Development
      PDS, Merck Enter Keytruda Clinical Combo Alliance

      PDS, Merck Enter Keytruda Clinical Combo Alliance

      Will evaluate PDS' Versamune-based immunotherapy with Merck's Keytruda in head and neck cancer and HPV16 infection
      07.10.17

    • Collaborations & Alliances | Drug Development | Toxicology
      CytomX Achieves $15M AbbVie Milestone

      CytomX Achieves $15M AbbVie Milestone

      Advances CD71-Targeting Probody Drug Conjugate into GLP toxicology studies  
      06.29.17


    • Biologics, Proteins, Vaccines | Drug Development | Industry News | R&D
      MilliporeSigma Expands Public Health England Distribution Pact

      MilliporeSigma Expands Public Health England Distribution Pact

      Provides customers greater access to a comprehensive suite of human iPSCs for disease modeling
      06.15.17

    • Industry News | Serialization
      Adents Implements Multi-Site, Multi-line Serialization Solution

      Adents Implements Multi-Site, Multi-line Serialization Solution

      Installs serialization solution on packaging lines at four sites in France
      06.08.17

    • Breaking News | Drug Delivery | Industry News | Inspections
      Tapemark Passes Regulatory Hurdle

      Tapemark Passes Regulatory Hurdle

      Manufacturing facility completes successful FDA pre-approval and general GMP inspection
      06.07.17


    • Inspections | Regulatory Affairs

      Warning Letters & Close-out Letters

      Why does it take so long to get a close-out letter?
      06.06.17

    • Breaking News | Industry News | Inspections
      BioPharma Services Completes 3 FDA Inspections

      BioPharma Services Completes 3 FDA Inspections

      No Form 483’s reported
      06.05.17

    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance
      05.26.17


    • Regulatory Affairs
      The FDA and Metrics

      The FDA and Metrics

      The Agency and industry continue to work together to achieve FDA’s objectives
      David Lonza, Lachman Consultant Services, Inc. 05.09.17

    • Analytical Services | Bio News | Bioanalytical Services | Breaking News | Industry News | Laboratory Testing
      Avantor to Acquire VWR for $6.4B

      Avantor to Acquire VWR for $6.4B

      Will create a vertically integrated, global player in manufacturing and supply chain solutions
      05.05.17

    • Cold Chain Management | Industry News | Logistics

      Cold Chain Technologies Opens New HQ

      Larger facility houses a manufacturing operation supported by thermal package engineering and an R&D center
      04.19.17


    • Trump Picks New FDA Commish

      Combatting high drug prices and overregulation likely to be high on agenda
      Tim Wright, Editor 04.03.17

    • Drug Delivery | Formulation Development | Industry News

      Capsugel Expands Late-Stage Inhalation Development Capabilities

      Adds Harro Hӧfliger Modu-C MS encapsulation unit at its Bend, OR facility
      03.30.17

    • Breaking News | Industry News | Lyophilization

      Permira Funds Acquires LSNE

      Matt Halvorsen will remain as LSNE’s chief executive
      03.27.17

    • Capsules | Solid Dosage/Semi-solids

      Generic Drug Trends

      Industry faces tighter capacity, consolidation, and drug pricing uncertainty
      Edward S. Price, President, PCI 03.07.17

    • Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Inspections | Lyophilization

      LSNE Completes Two FDA Inspections

      FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully
      03.06.17

    • APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Facilities | Industry News

      Patheon Completes Acquisition of Mfg. Site

      Gains additional API capacity and major supply agreement with Roche
      02.03.17

    • QA/QC | Regulatory Affairs
      FDA’s Quality Agreements Guidance

      FDA’s Quality Agreements Guidance

      Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry
      Paul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17

    • Analytical Services | Bioanalytical Services | Industry News | Laboratory Testing

      SGS Expands E&L Capacity

      Two additional instruments have been installed and validated
      01.25.17